Methotrexate (MTX) is an effective drug used to treat various diseases, especially rheumatological diseases. However, myelosuppression is a severe side effect, the frequency of which increases in patients with renal insufficiency. Here, we presented a chronic hemodialysis patient who developed pancytopenia and mucositis after using low-dose MTX to treat psoriasis.
Primary Language | English |
---|---|
Subjects | Internal Diseases |
Journal Section | Case Reports |
Authors | |
Publication Date | April 1, 2022 |
Submission Date | February 15, 2022 |
Acceptance Date | March 9, 2022 |
Published in Issue | Year 2022 Volume: 4 - Supplement 1 |